Company news

bioMerieux SA news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics

October 21, 2026

WHO Grants Emergency Use Listing for BIOFIRE Global Fever Special Pathogens Panel, Expanding Access to Differential Diagnostics for the Ebola Response

October 19, 2026

WHO Grants Emergency Use Listing for BIOFIRE® Global Fever Special Pathogens Panel, Expanding Access to Differential Diagnostics for the Ebola Response

October 18, 2026

Septembre 2026 - Déclaration sur le nombre d\'actions composant le capital social et sur le nombre de droits de vote correspondant

September 30, 2026

bioMerieux: BioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification

September 16, 2026

bioMérieux Highlights Positive Impacts of Rapid, Accurate Diagnostics for Patients and Accepts Industry Awards at ADLM 2026

August 7, 2026

BioMérieux – First-Half 2026 Results

July 28, 2026

bioMérieux introduces Salmonella testing kit on GENE-UP® TYPER to support root cause analysis in the food industry

June 18, 2026

AG 2026 - 2025 Parent company financial statements

May 4, 2026

AG 2026 - 2025 Consolidated financial statements

May 4, 2026

AG 2026 - Statutory auditors' report - 2025 Parent company annual financial statements

May 4, 2026

AG 2026 - Statutory auditors' report - 2025 consolidated financial statements

May 4, 2026

BioMérieux – First-Quarter 2026 Business Review

April 23, 2026

First-Quarter 2026 Business Review

April 23, 2026

First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries

April 20, 2026

BioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing

April 9, 2026

Communiqué de mise à disposition du Document d'enregistrement universel 2025 incluant le Rapport Financier Annuel

March 17, 2026

bioMérieux launches SMARTBIOME™ to help food manufacturers gain deeper insights into spoilage and protect product quality

February 18, 2026

Commonwealth Fusion Systems Names Stephane Bancel to Board of Directors

January 12, 2026

OhioHealth Partners with bioMérieux as Newest Global Antimicrobial Stewardship Center of Excellence

August 26, 2025

bioMérieux Develops Game Changing Quality Control Solution GENE-UP® PRO HRM

August 5, 2025

Calls

Decks

The 5 newest of 38 decks. Every deck is listed under its year.